Referencias bibliográficas

  1. Palacios S, Stevenson JC, Schaudig K, et al . Hormone therapy for first-line management of menopausal symptoms: Practical recommendations. Womens Health (Lond). 2019 Jan-Dec;15:1745506519864009. doi: 10.1177/1745506519864009
  2. Nieto L, Bravo EM, Cuerva MJ. Manual básico de Menopausia [Internet]. 2020. 1–107 p. Available from: https://aeem.es/wp-content/uploads/2020/05/n1870_libro-jovenes-aeem-04-05-20-baja12.pdf
  3. Palacios S. Prevalence and impact on quality of life of vasomotor symptoms. Menopause. 2021 May 17;28(8):850-851
  4. Proserpio P, Marra S, Campana C, Agostoni EC, Palagini L, Nobili L, et al. Insomnia and menopause: a narrative review on mechanisms and treatments. Climacteric [Internet]. 2020;23(6):539–49.
  5. Genazzani AR, Schneider HP, Panay N, et al. The European Menopause Survey 2005: women’s perceptions on the menopause and postmenopausal hormone therapy. Gynecol Endocrinol 2006;22:369-375
  6. Gracia CR, Freeman EW. Onset of the Menopause Transition: The Earliest Signs and Symptoms. Obstet Gynecol Clin North Am [Internet]. 2018;45(4):585–97
  7. Palacios S, Mejía A, Neyro JL. Treatment of the genitourinary syndrome of menopause. Climacteric. 2015;18 Suppl 1:23-9
  8. Palacios S. Medical treatment of osteoporosis. Climacteric. 2022 Feb;25(1):43-49
  9. Baber RJ., Panay N., Fenton A. et al.: 2016 IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016, 19: 109-50
  10. Nonhormonal management of menopause-associeted vasomotor symptoms: 2015 position statement of The North American Menopasue Society. Menopause 2015; 11: 1155-1172.
  11. Rada G, Capurro D, Pantoja T, Corbaán J, Moreno G, Letelier LM, et al. Non-hormonal interventions for hot flushes in women with a history of breast cáncer. Cochrane Database of Systematic Reviews, 2010; 9: CD004923
  12. Heinemann K, Ruebig A, Potthoff P, et al. The Menopause Rating Scale (MRS) scale: A methodological review. Health Qual Life Outcomes. 2004;2:1–8.
  13. Brown JP, Don-Wauchope A, Douville P, 2et al. Current use of bone turnover markers in the management of osteoporosis. Clin Biochem. 2022 Nov-Dec;109-110:1-10
  14. McIntyre IM, Norman TR, Burrows GD, et al. Melatonin rhythm in human plasma and saliva. J Pineal Res. 1987;4(2):177-83
  15. Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2:1–13.
  16. Sundberg, M. Ramklint, M. Stridsberg, et alSalivary melatonin in relation to depressive symptom severity in young adults. PLoS One, 11 (2016), Article e0152814
  17. Chen LR, Chen KH. Utilization of Isoflavones in Soybeans for Women with Menopausal Syndrome: An Overview. Int J Mol Sci. 2021 Mar 22;22(6):3212. doi: 10.3390/ijms22063212. PMID: 33809928; PMCID: PMC8004126
  18. The role of isoflavones in menopausal health: consensus opinion of The North American Menopause Society. Menopause. 2000 Jul-Aug;7(4):215-29
  19. Odai T, Terauchi M, Hirose A, Kato K, Akiyoshi M, Miyasaka N. Severity of hot flushes is inversely associated with dietary intake of vitamin B6 and oily fish. Climacteric. 2019 Dec;22(6):617-621
  20. Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci. 2011 May;73(3):255-61
  21. Laudisio D, Barrea L, Pugliese G, Aprano S, Castellucci B, Savastano S, Colao A, Muscogiuri G. A practical nutritional guide for the management of sleep disturbances in menopause. Int J Food Sci Nutr. 2021 Jun;72(4):432-446
  22. Shaarawy M, Hasan M. Serum bone sialoprotein: a marker of bone resorption in postmenopausal osteoporosis. Scand J Clin Lab Invest. 2001;61(7):513-21